Abstract:AIMSAcute administration of aspirin increases nitric oxide (NO) synthesis by platelets, an effect not shared by other non-steroidal anti-inflammatory drugs. The aim of the present study was to determine the mechanism by which aspirin acutely increases the activity of NO synthase type 3 (NOS-3), the predominant NOS isoform expressed by platelets, and specifically whether this occurs through an increase in its acetylation.METHODS AND RESULTSPlatelets isolated from the blood of healthy human subjects were exposed in vitro to vehicle or aspirin at different concentrations (5 micromol/L-4 mmol/L). Changes in intraplatelet Ca(2+) concentration were determined from fura-2 fluorescence. Following immunoprecipitation of NOS-3 from platelet lysates, its activity was determined from l-[(3)H]arginine to l-[(3)H]citrulline conversion, and its serine phosphorylation quantified by western blotting. Acetylation of NOS-3 in platelets was assessed by the incorporation of radioactivity into the immunoprecipitated enzyme from [acetyl-(14)C]aspirin. Following transfection of HeLa cells with NOS-3, NO biosynthesis in response to aspirin was determined from cyclic GMP measurement, and sites of NOS-3 acetylation were ascertained by liquid chromatography-tandem mass spectrometry. At all concentrations tested, aspirin increased the activity of NOS-3 from platelets. This was not associated with any measurable change in intraplatelet Ca(2+) concentration. Serine phosphorylation of NOS-3 in platelets was decreased, and this was especially marked for serine-1177 phosphorylation, whereas acetylation of NOS-3 was increased, by aspirin incubation. HeLa cells transfected with NOS-3 exhibited an increase in NO biosynthesis following aspirin exposure, and this was associated with acetylation of the enzyme on both serine-765 and serine-771.CONCLUSIONAspirin acetylates NOS-3 acutely in platelets, and this causes an increase in its activity as well as a decrease in its phosphorylation. It is also possible that aspirin indirectly affects NOS-3 activity by acetylating other substrates within the platelet, but this remains to be determined.

Studies on Antithrombotic Activities of NO Donating-Aspirin Derivatives

Design, Synthesis and Evaluation of Nitric Oxide Releasing Derivatives of 3-N-butylphthalide As Antiplatelet and Antithrombotic Agents.

Synthesis and Antithrombotic Activity of Acetylsalicyl Ferulic Acid-Coupling Furoxans and Nitrates

Synthesis and Evaluation of Novel Nitric Oxide-Donating Ligustrazine Derivatives as Potent Antiplatelet Aggregation Agents

Synthesis and biological evaluation of nitric oxide releasing derivatives of 6-amino-3-n-butylphthalide as potential antiplatelet agents.

Aspirin Acetylates Nitric Oxide Synthase Type 3 in Platelets Thereby Increasing Its Activity.

Synthesis and Antithrombotic Activity of 3-Aryl-1,2,3,4-oxatriazole-5-imine-coupled Aspirin

Design, Synthesis And Biological Evaluation Of Hydrogen Sulfide Releasing Derivatives Of 3-N-Butylphthalide As Potential Antiplatelet And Antithrombotic Agents

Synthesis and anti-platelet activities of nitric oxide-releasing derivatives of 3-butylphthalide

Synthesis of N-6-Alkyl(Aryl)-2-Alkyl(Aryl)Thioadenosines As Antiplatelet Agents

[Design, Synthesis and Antiasthmatic Activities of NO-donating Seratrodast Derivatives].

Synthesis and Biological Activities of Derivatives of Aspirin and Methyl Salicylate

Synthesis and Biological Evaluation of Nitric Oxide (No)-Hydrogen Sulfide (h2s) Releasing Derivatives of (S)-3-n-butylphthalide As Potential Antiplatelet Agents

The effect of L-arginine L-aspartate on arterial thrombosis model and its mechanism

The Investigation of Pharmacokinetics and Pharmacodynamics on Different Doses and Administratire Ways of Aspirin

A Naphthalenic Derivative ND-1 Inhibits Thrombus Formation by Interfering the Binding of Fibrinogen to Integrin Αiibβ3.

Synthesis and biological evaluation of N 6 derivatives of 8-azapurine as novel antiplatelet agents

Synthesis and Biological Evaluation of N-Butylphthalide Derivatives As Anti-Platelet Aggregation Agents

Effects of a novel hydrogen sulfide-releasing aspirin (ACS-14) on platelet aggregation

Selective binding of cationic fibrinogen-mimicking chitosan nanoparticles to activated platelets and efficient drug release for antithrombotic therapy

Effects of 1-(Cinnamoyl)-4-(phenylethylamine Acetyl) Piperazine Maleate on Platelet Aggregation and Thrombosis